FyoniBio GmbH

FyoniBio is Berlin based CDO specialized in cell line and process development for the production of biologics. The portfolio includes CHOnamite® and CHOFlow® platform technologies as well as the human GlycoExpress® platform. To be a one-stop-shop, FyoniBio cooperates with selected GMP partners around the world.

Furthermore, FyoniBio provides state-of-the-art CMC analyses, including mass spectrometry, with a focus on glycan and other post-translational modifications (PTMs).

Another area is the development and validation of tailored PK, PD, ADA, and biomarker assays, analyzing clinical samples in compliance with GCLP and current ICH, FDA, and EMA guidelines.